Joshua Richter, MD from John Theurer Cancer Center discusses GBR 1342 studies in phase 1 and search for the maximum tolerated dose at the 2017 American Society of Hematology.
Joshua Richter, MD from John Theurer Cancer Center discusses GBR 1342 studies in phase 1 and search for the maximum tolerated dose at the 2017 American Society of Hematology.